Dr. Roxie has created a community where leading health innovators can share their journey. The debrief on the Pear Therapeutics demise was excellent with terrific insights that drove our breakout discussions.
We discussed the fact that PT expanded their product offering too quickly. They therefore built a sales team too quickly and assumed a high burn rate before successful at their primary solution. They also made the product unaffordable to a consumer audience who were the ultimate target. There were other products on the market that addressed the problem at much lower price points.